Glial progenitor-like state is preferentially co-opted in glioblastoma and sustained by POU3F3
Authors:
- Susana I. RamosSRSusana I. Ramos
- Mohammad Imran K. KhanMKMohammad Imran K. Khan
- Wan Sze ChengWCWan Sze Cheng
- Balagopal PaiBPBalagopal Pai
- Thenzing J. Silva-HurtadoTSThenzing J. Silva-Hurtado
- Jorge SamanamudJSJorge Samanamud
- Xi ChenXCXi Chen
- Kristin G. BeaumontKBKristin G. Beaumont
- Robert P. SebraRSRobert P. Sebra
- Raymund L. YongRYRaymund L. Yong
- Timothy E. RichardsonTRTimothy E. Richardson
- Amanda KrausertAKAmanda Krausert
Abstract
No abstract availableFunding Information
- Intramural Research Program
- National Institute of Neurological Disorders and Stroke
This publication has 82 references indexed in Scilit:
- GABAergic neuronal lineage development determines clinically actionable targets in diffuse hemispheric glioma, H3G34-mutantCancer Cell, 2024
- Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastomaCancer Cell, 2022
- The ribosomal protein eL21 interacts with the protein lysine methyltransferase SMYD2 and regulates its steady state levelsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2021
- De Novo Variants Disturbing the Transactivation Capacity of POU3F3 Cause a Characteristic Neurodevelopmental DisorderThe American Journal of Human Genetics, 2019
- Comprehensive Integration of Single-Cell DataCell, 2019
- Long non-coding RNA LOC730100 enhances proliferation and invasion of glioma cells through competitively sponging miR-760 from FOXA1 mRNABiochemical and Biophysical Research Communications, 2019
- Determination and Inference of Eukaryotic Transcription Factor Sequence SpecificityCell, 2014
- Advances in genetic and epigenetic analyses of gliomas: a neuropathological perspectiveJournal of Neuro-Oncology, 2014
- Mesenchymal Differentiation Mediated by NF-κB Promotes Radiation Resistance in GlioblastomaCancer Cell, 2013
- Deletions of NRXN1 (neurexin‐1) predispose to a wide spectrum of developmental disordersAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2010